Search results for "BIPOLAR"

showing 10 items of 395 documents

Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis.

2018

Background: Treatment-emergent mania (TEM) represents a common phenomenon inconsistently reported across primary studies, warranting further assessment. Methods: A systematic review and meta-analysis following the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) and Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines were conducted. Major electronic databases were searched from inception to May 2017 to assess the incidence and prevalence rates and clinical features associated with manic switch among bipolar depressed patients receiving antidepressants, using meta-regression and subgroup analysis. Results: Overall, 10 098 depressed patients wit…

medicine.medical_specialtyBipolar DisorderSubgroup analysismeta-analysinot knownlaw.invention03 medical and health sciences0302 clinical medicineantidepressant; bipolar disorder; incidence; meta-analysis; switch; systematic reviewsystematic reviewRandomized controlled triallawInternal medicinemedicinePrevalenceHumansCumulative incidenceBipolar disorderBiological Psychiatryantidepressantbusiness.industryDepressionIncidence (epidemiology)Incidencemedicine.diseaseswitchConfidence intervalAntidepressive Agents030227 psychiatrymeta-analysisPsychiatry and Mental healthMeta-analysismedicine.symptombusinessMania030217 neurology & neurosurgeryBipolar disorders
researchProduct

Prepare the smoking cessation in severe mental illness: Early diagnosis and prevention opportunities

2019

medicine.medical_specialtyBipolar Disorderbusiness.industrymedicine.medical_treatmentSmokingMEDLINESmoking PreventionHealth PromotionGeneral MedicineMental illnessmedicine.diseaseEarly DiagnosisPatient Education as TopicSchizophrenic PsychologymedicineHumansSmoking cessationSchizophrenic PsychologySmoking CessationPsychiatrybusinessRandomized Controlled Trials as TopicRevista de Psiquiatría y Salud Mental (English Edition)
researchProduct

Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: Systematic …

2020

BackgroundThe elderly population and numbers of nursing homes residents are growing at a rapid pace globally. Uncertainty exists regarding the actual rates of major depressive disorder (MDD), bipolar disorder and schizophrenia as previous evidence documenting high rates relies on suboptimal methodology.AimsTo carry out a systematic review and meta-analysis on the prevalence and correlates of MDD, bipolar disorder and schizophrenia spectrum disorder among nursing homes residents without dementia.MethodMajor electronic databases were systematically searched from 1980 to July 2017 for original studies reporting on the prevalence and correlates of MDD among nursing homes residents without demen…

medicine.medical_specialtyBipolar Disorderdepressive disorder (MDD)PopulationreviewPrevalenceMajor depressive disordernursing homesbehavioral disciplines and activitiesmeta-analysi03 medical and health sciences0302 clinical medicinemental disordersPrevalencemedicineHumansDementiaBipolar disorderPsychiatryeducationAgedDepressive Disorder Majoreducation.field_of_study030214 geriatricsbusiness.industryPublication biasmedicine.diseaseNursing Homes030227 psychiatrymeta-analysisnursing homePsychiatry and Mental healthSchizophreniaMeta-analysisSchizophrenialong-term careMajor depressive disorderDementiabusiness
researchProduct

Lifestyle interventions targeting dietary habits and exercise in bipolar disorder: A systematic review.

2015

Abstract Background Bipolar disorder (BD) is a serious mental illness associated with a high risk of medical comorbidities, long-term disability and premature death. This systematic review examined the current literature on therapeutic interventions targeting nutrition, physical activity and wellness in BD and collecting health-related measures such as mood and course of illness. Methods Scopus (all databases), Pubmed and Ovid Medline were systematically searched with no language or year restrictions, up to June 2015, for studies focusing on lifestyle interventions in BD. Search terms were related to bipolar disorder, nutrition, physical activity, wellbeing, psychosocial interventions and c…

medicine.medical_specialtyBipolar Disordereducation.educational_degreePsychological interventionPsychiatric rehabilitationPsychiatric RehabilitationArticlelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawMedicineHumansBipolar disorderPsychiatryeducationExerciseLife StyleBiological Psychiatrybusiness.industryFeeding BehaviorMental illnessmedicine.disease030227 psychiatryPsychiatry and Mental healthMoodInclusion and exclusion criteriabusinessPsychosocial030217 neurology & neurosurgeryClinical psychologyJournal of psychiatric research
researchProduct

The prevalence and predictors of bipolar and borderline personality disorders comorbidity: Systematic review and meta-analysis

2016

Introduction Data about the prevalence of borderline personality (BPD) and bipolar (BD) disorders comorbidity are scarce and the boundaries remain controversial. We conducted a systematic review and meta-analysis investigating the prevalence of BPD in BD and BD in people with BPD. Methods Two independent authors searched MEDLINE, Embase, PsycINFO and the Cochrane Library from inception till November 4, 2015. Articles reporting the prevalence of BPD and BD were included. A random effects meta-analysis and meta-regression were conducted. Results Overall, 42 papers were included: 28 considering BPD in BD and 14 considering BD in BPD. The trim and fill adjusted analysis demonstrated the prevale…

medicine.medical_specialtyBipolar Disordermedia_common.quotation_subjectMEDLINEbipolar (BD) disordersPsycINFOComorbidityCochrane LibraryBorderline personality disorder (BPD)behavioral disciplines and activitiesborderline personality (BPD03 medical and health sciences0302 clinical medicineBorderline Personality DisorderInternal medicinemental disordersmedicinePrevalencePersonalityHumansMeta-regressionMeta-analysimedia_commonPredictorsmedicine.diseaseBipolar disorder (BD)ComorbidityPersonality disorders030227 psychiatryBipolar disorder (BD); Borderline personality disorder (BPD); Comorbidity; Meta-analysis; Predictors; Prevalence; Systematic review; Psychiatry and Mental Health; Clinical PsychologyMeta-analysisClinical PsychologyPsychiatry and Mental HealthMeta-analysisSystematic reviewPsychology030217 neurology & neurosurgeryClinical psychologyPredictorHuman
researchProduct

The effect of concomitant benzodiazepine use on neurocognition in stable, long-term patients with bipolar disorder

2020

Objective: Neurocognitive dysfunction is a common feature of bipolar disorder even in euthymia, and psychopharmacological treatment could have an effect on cognition. Long-term prescription of benzodiazepines in bipolar disorder is a common practice, and their effect on neurocognition has not been well studied in this population. The aim of this study was to evaluate the impact of concomitant benzodiazepine long-term use on neurocognitive function in stable euthymic bipolar disorder patients. Methods: Seventy-three euthymic bipolar disorder outpatients and 40 healthy individuals were assessed using a neurocognitive battery. Patients were classified in two groups according to the presence of…

medicine.medical_specialtyBipolar Disordermedicine.drug_classNeuropsychological TestsBenzodiazepinesExecutive Function03 medical and health sciencesCognition0302 clinical medicinemedicineHumansBipolar disorderMedical prescriptionPsychiatryBenzodiazepinebusiness.industryCognitionGeneral Medicinemedicine.disease030227 psychiatryTerm (time)Psychiatry and Mental healthFeature (computer vision)ConcomitantbusinessNeurocognitive030217 neurology & neurosurgeryAustralian & New Zealand Journal of Psychiatry
researchProduct

Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysi…

2010

In recent years, combinations of pharmacological treatments have become common for the treatment of bipolar disorder type I (BP I); however, this practice is usually not evidence-based and rarely considers monotherapy drug regimen (MDR) as an option in the treatment of acute phases of BP I. Therefore, we evaluated comparative data of commonly prescribed MDRs for both manic and depressive phases of BP I. Medline, PsycINFO, EMBASE, the Cochrane Library, the ClinicalStudyResults.org and other data sources were searched from 1949 to March 2009 for placebo and active controlled randomized clinical trials (RCTs). Risk ratios (RRs) for response, remission, and discontinuation rates due to adverse …

medicine.medical_specialtyBipolar I disorderBipolar DisorderDatabases FactualPharmacologyLithiumArticlelaw.inventionTreatment of bipolar disorderRandomized controlled triallawInternal medicinemental disordersmedicineAnimalsHumansManic-depressive illnessPharmacology (medical)Bipolar disorderAntipsychotic drugsRandomized Controlled Trials as TopicPharmacologyTrastorn bipolarbusiness.industrymedicine.diseaseLitiAntidepressive AgentsDiscontinuationPsychiatry and Mental healthAcute DiseaseNumber needed to treatAnticonvulsiusQuetiapineDrug EvaluationAntipsicòticsAnticonvulsantsmedicine.symptombusinessManiamedicine.drug
researchProduct

Comparing neurocognitive impairment in schizophrenia and bipolar I disorder using the Screen for Cognitive Impairment in Psychiatry Scale

2014

AbstractThe purpose of this study was to compare the psychometric properties of the Screen for Cognitive Impairment in Psychiatry (SCIP) when applied to patients diagnosed with schizophrenia (n=126) or bipolar I disorder (n=76), and also to compare the cognitive impairment in both samples of patients and a control group (n=83) using the SCIP and a complete neuropsychological battery. The SCIP is a scale intended to quickly and easily assess cognitive impairment in patients with severe psychiatric disorders. The results showed firstly that, in terms of internal consistency, temporal stability, dimensional structure, and criterion-referenced validity, the SCIP provides reliable and valid scor…

medicine.medical_specialtyBipolar I disorderCognition disordersBipolar disorderlcsh:BF1-990EsquizofreniaDeterioro cognitivoTrastorns de la cognicióInstrumental studymedicineManic-depressive illnessIn patientBipolar disorderCognitive impairmentPsychiatryTrastorn bipolarTrastorno bipolarEstudio instrumentalNeuropsychological batterymedicine.diseaseScreen for Cognitive Impairment in PsychiatryClinical PsychologyCognitive impairmentlcsh:PsychologySchizophreniaSchizophreniaEsquizofrèniaVerbal memoryPsychologyNeurocognitiveInternational Journal of Clinical and Health Psychology
researchProduct

Neurocognitive impairment and psychosocial functioning in bipolar II disorder

2011

Sole B, Bonnin CM, Torrent C, Balanza-Martinez V, Tabares-Seisdedos R, Popovic D, Martinez-Aran A, Vieta E. Neurocognitive impairment and psychosocial functioning in bipolar II disorder. Objective:  There is a growing body of evidence on neurocognitive impairment in euthymic bipolar patients, but this issue has been studied mostly in bipolar I disorder, data on bipolar II (BD-II) are scant and discrepant. The two aims of this study were to ascertain whether strictly defined euthymic BD-II patients would present neurocognitive disturbances and to evaluate their impact on functional outcome. Method:  Forty-three BD-II patients and 42 demographically and educationally matched healthy subjects …

medicine.medical_specialtyBipolar I disorderTrail Making TestHamilton Rating Scale for DepressionVerbal learningmedicine.diseaseYoung Mania Rating ScalePsychiatry and Mental healthBipolar II disorderHypomaniamedicinemedicine.symptomPsychologyPsychiatryNeurocognitiveActa Psychiatrica Scandinavica
researchProduct

Characteristics of bipolar disorder patients given antidepressants

2012

Evidence concerning efficacy of antidepressants in bipolar disorder remains inconsistent and inconclusive. As the appropriate clinical use for such patients remains unclear, we characterized outpatients with bipolar disorders who were or were not treated with antidepressants. Clinical data were collected systematically from consecutive outpatients in 11 participating Argentine mood-disorder clinics in 2007–2008. Diagnoses met DSM-IV criteria, supported by structured interviews based on the MINI-500. Of 338 outpatients diagnosed with bipolar I (45.0%), II (29.3%), or not-otherwise-specified (NOS) (25.7%) disorder, 128 (37.9%) received antidepressants. Subjects given antidepressants or not di…

medicine.medical_specialtyBipolar I disorderbusiness.industrymedicine.diseaseAntimanic AgentsPsychiatry and Mental healthNeurologyInternal medicineMedicineOutpatient clinicAntidepressantPharmacology (medical)Neurology (clinical)Bipolar disorderbusinessPsychiatryDepression (differential diagnoses)Human Psychopharmacology: Clinical and Experimental
researchProduct